Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Article
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Writing the Future of Biologics to Discover and Optimize Antibodies
Presented by
Steven Thomas
Twist Biopharma, a division of Twist Bioscience
Covered in this Webinar
Learn about the Hyperimmune Library for therapeutic development against virtually any target.
Hear how the latest libraries are opening new sequence space, allowing researchers to focus on difficult-to-drug targets like GPCR
Compare options for accessing the Library of Libraries, including licensing or partnering to fully outsource lead discovery
Monoclonal antibodies have become the preferred therapeutic modality for cancer, infectious diseases, inflammatory and autoimmune disorders, and other conditions.
Twist Bioscience is on a mission to support this work, offering a Library of Libraries containing multiple pre-constructed and validated libraries against many high-value targets with which scientists can build a comprehensive and robust antibody discovery platform.
Here we introduce the latest addition to our Library of Libraries: the Hyperimmune Library.
Join our webinar with Steven Thomas from Twist Biopharma, a division of Twist Bioscience, to:
- Review recent work from Twist Biopharma using the Library of Libraries against human ACE2 and the SARS-CoV-2 spike protein to find potently neutralizing candidate antibodies against the SARS-CoV-2 strain of coronavirus in under 4 weeks.
Share your details to Watch the Webinar
